Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 28 Mar 2024 for Pyxis Oncology, Inc.. Read the official filing
Filing timeline
BuySaleJakob Dupont
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jakob Dupont: trading record in brief
Jakob Dupont (senior executive) discloses dealings in 3 companies, chiefly Atara Biotherapeutics, Inc., OncoMed Pharmaceuticals Inc and Pyxis Oncology, Inc. We count 19 filings; the first trade dates from 6 January 2016 and the latest from 26 March 2024.
Every open-market trade on record is a sale: 11 sales worth €189k. No amount is published for 4 filings, which the totals therefore leave out. Besides market trades, the filings include 3 share grants and 5 option exercises.
On 28 March 2024 came the latest disclosure, a share grant in Pyxis Oncology, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jakob Dupont
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
38,741 shares0Common StockSEC:0000950170-24-038102:0
5,074 shares@ US$3.6274.1% of flowCommon StockSEC:0001567619-23-004537:0
141,328 shares0Common StockSEC:0001140361-23-010100:0
3,218 shares@ US$4.493.3% of flowCommon StockSEC:0001140361-22-042381:0
4,124 shares@ US$5.0344.9% of flowCommon StockSEC:0001140361-22-030300:0
3,873 shares@ US$5.3180.024% mcap5.3% of flowCommon StockSEC:0001140361-22-019981:0
78,506 shares0Common StockSEC:0001140361-22-007765:0
5,000 shares@ US$9.5811.8% of flowCommon StockSEC:0001567619-22-004499:0
5,000 shares@ US$9.5811.8% of flowCommon StockSEC:0001567619-22-000568:0
5,000 shares@ US$9.5811.9% of flowCommon StockSEC:0001567619-21-021583:0
2,199 shares@ US$17.11699.3% of flowCommon StockSEC:0001567619-21-020777:0
5,000 shares@ US$9.5811.6% of flowCommon StockSEC:0001567619-21-019331:0
2,152 shares@ US$12.5326.5% of flowCommon StockSEC:0001567619-21-016145:0
5,184 shares@ US$14.5517.3% of flowCommon StockSEC:0001209191-21-034428:0
2,500 sharesCommon StockSEC:0001140361-16-047651:0
2,500 sharesCommon StockSEC:0001140361-16-047651:1
2,092 sharesCommon StockSEC:0001140361-16-047340:0
69 sharesCommon StockSEC:0001140361-16-047340:1
1 sharesCommon StockSEC:0001140361-16-047340:2
19 of 19 declarations
